Barinthus Bio sets 0.111 share exchange ratio for Clywedog deal

Reuters2026/08/24 22:57

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Barinthus Biotherapeutics’ combination with Clywedog is now expected to take effect on Sept. 3, 2026.
Trading in Barinthus Bio ADSs on Nasdaq is expected to halt before the market opens on Sept. 3.
The scheme exchange ratio was set at 0.111 for Topco common stock issued in exchange for scheme shares.
Topco common stock is expected to begin trading on Nasdaq under the ticker CLYD once the deal closes.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Barinthus Biotherapeutics plc published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202608241857PRIMZONEFULLFEED9815323) on August 24, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Barinthus Bio sets 0.111 share exchange ratio for Clywedog deal

You may also like

Crypto prices